Status:
ACTIVE_NOT_RECRUITING
CYP2D6 Genotype-guided Management of Opioid Analgesics in Patients Undergoing Elective Ventral Hernia Repairs
Lead Sponsor:
University of Florida
Conditions:
Ventral Hernia
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Pilot pragmatic trial using an implementation science approach to determine the feasibility of a CYP2D6-guided opioid prescribing for patients undergoing elective VHRs compared to usual care. Assess t...
Eligibility Criteria
Inclusion
- \> 18 years age undergoing a ventral hernia repair (VHR) ≥1.5 cm in diameter with mesh.
Exclusion
- ventral hernia \<1.5 cm
- primary ventral hernia repair (VHR) without a mesh
- emergency operative procedure
- receiving chronic opioid therapy (defined as use of opioids on most days for \>3 months)
- allergy to opioids
- women of childbearing potential who have a positive pregnancy result as part of their standard pre-surgical workup
Key Trial Info
Start Date :
January 29 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06565546
Start Date
January 29 2025
End Date
July 1 2026
Last Update
January 8 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida Jacksonville
Jacksonville, Florida, United States, 32209